{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:18:36Z","timestamp":1793945916111,"version":"4.8.0"},"reference-count":417,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001422"],"award-info":[{"award-number":["UL1TR001422"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007059","name":"Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23 HL136891"],"award-info":[{"award-number":["K23 HL136891"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL151367"],"award-info":[{"award-number":["R01HL151367"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001424","name":"American Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001424","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.cgh.2021.07.018","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T05:18:40Z","timestamp":1626326320000},"page":"1636-1662.e36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":224,"title":["North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension"],"prefix":"10.1016","volume":"20","author":[{"given":"Justin R.","family":"Boike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartley G.","family":"Thornburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet K.","family":"Asrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Fallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett E.","family":"Fortune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manhal J.","family":"Izzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Verna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan G.","family":"Abraldes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Allegretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmohan S.","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Biggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Darcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryjane A.","family":"Farr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khashayar","family":"Farsad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Garcia-Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley A.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline C.","family":"Jadlowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Krowka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Laberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Mulligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra K.","family":"Nadim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Northup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Shatzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathryn J.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Simonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Susman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Pallav","family":"Kolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa B.","family":"VanWagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2021.07.018_bib1","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib2","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/gutjnl-2018-317057","article-title":"Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study","volume":"68","author":"Lv","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.07.018_bib3","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garcia-Pagan","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","article-title":"Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites","volume":"152","author":"Bureau","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ajg.2009.634","article-title":"Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis","volume":"105","author":"Dhanasekaran","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.dld.2018.01.123","article-title":"Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: a systematic review and meta-analysis","volume":"50","author":"Song","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib7","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2001.03694.x","article-title":"Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation","volume":"96","author":"Mezawa","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib8","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jvir.2015.12.013","article-title":"National trends and outcomes of transjugular intrahepatic portosystemic shunt creation using the nationwide inpatient sample","volume":"27","author":"Trivedi","year":"2016","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib9","doi-asserted-by":"crossref","first-page":"G275","DOI":"10.1152\/ajpgi.00094.2017","article-title":"Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis","volume":"314","author":"Busk","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00270-018-2040-y","article-title":"Transjugular intrahepatic portosystemic shunt using the new Gore Viatorr controlled expansion endoprosthesis: prospective, single-center, preliminary experience","volume":"42","author":"Miraglia","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1055\/s-0038-1660800","article-title":"New techniques and devices in transjugular intrahepatic portosystemic shunt placement","volume":"35","author":"RiChard","year":"2018","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib12","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.cgh.2021.07.018_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1287\/mnsc.9.3.458","article-title":"An experimental application of the DELPHI method to the use of experts","volume":"9","author":"Dalkey","year":"1963","journal-title":"Manage Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib14","series-title":"The 2011 Oxford CEBM levels of evidence","author":"Howick","year":"2011"},{"key":"10.1016\/j.cgh.2021.07.018_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.23383","article-title":"The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009","volume":"51","author":"Boyer","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvir.2015.09.018","article-title":"Quality improvement guidelines for transjugular intrahepatic portosystemic shunts","volume":"27","author":"Dariushnia","year":"2016","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jvir.2012.10.026","article-title":"Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation","volume":"24","author":"Gaba","year":"2013","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib18","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib19","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"10.1016\/j.cgh.2021.07.018_bib21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1572-0241.2003.07515.x","article-title":"Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting","volume":"98","author":"Schepke","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10620-010-1390-3","article-title":"Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS","volume":"56","author":"Al Sibae","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00042737-200406000-00015","article-title":"Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment","volume":"16","author":"Alessandria","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10620-016-4185-3","article-title":"Transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis and model for end-stage liver disease \u226515","volume":"62","author":"Ascha","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217442","article-title":"Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement","volume":"14","author":"Allegretti","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2021.07.018_bib27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1148\/radiol.2311030967","article-title":"Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score","volume":"231","author":"Ferral","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2021.07.018_bib28","article-title":"Short outcome comparison of elderly patients versus nonelderly patients treated with transjugular intrahepatic portosystemic stent shunt: a propensity score matched cohort study","volume":"96","author":"Li","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2021.07.018_bib29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/MCG.0000000000000541","article-title":"Age-related morbidity and mortality after transjugular intrahepatic portosystemic shunts","volume":"51","author":"Suraweera","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib30","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jhep.2020.04.024","article-title":"Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS","volume":"73","author":"Trebicka","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2017.05.006","article-title":"Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding","volume":"67","author":"Wang","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1148\/radiol.2017161644","article-title":"Transjugular intrahepatic portosystemic shunts in patients with cirrhosis with refractory ascites: comparison of clinical outcomes by using 8- and 10-mm PTFE-covered stents","volume":"284","author":"Miraglia","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2021.07.018_bib33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ki.1995.32","article-title":"Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol cooperative study","volume":"47","author":"Rudnick","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.cgh.2021.07.018_bib34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0002-9343(89)90437-3","article-title":"Dosing of contrast material to prevent contrast nephropathy in patients with renal disease","volume":"86","author":"Cigarroa","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib35","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib36","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2021.07.018_bib37","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1572-0241.2004.04056.x","article-title":"Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results","volume":"99","author":"Angeloni","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib40","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejrad.2004.10.007","article-title":"Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents","volume":"55","author":"Barrio","year":"2005","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib41","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/01.RVI.0000137434.19522.E5","article-title":"Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation","volume":"15","author":"Charon","year":"2004","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.RVI.0000116194.44877.C1","article-title":"Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft","volume":"15","author":"Hausegger","year":"2004","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2214\/ajr.178.1.1780141","article-title":"Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures","volume":"178","author":"Otal","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cgh.2021.07.018_bib44","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jhep.2014.01.015","article-title":"Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial","volume":"60","author":"Perarnau","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2010.02.033","article-title":"Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial","volume":"53","author":"Riggio","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00042737-200603000-00001","article-title":"Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents","volume":"18","author":"Tripathi","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib47","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jvir.2010.06.009","article-title":"Stent-grafts for transjugular intrahepatic portosystemic shunt creation: specialized TIPS stent-graft versus generic stent-graft\/bare stent combination","volume":"21","author":"Saad","year":"2010","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jvir.2016.06.023","article-title":"Prospective evaluation of passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stent grafts-a three-dimensional sonography study","volume":"28","author":"Pieper","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jvir.2014.10.021","article-title":"Postinterventional passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stents","volume":"26","author":"Pieper","year":"2015","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib50","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib51","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/hep.28148","article-title":"Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial","volume":"63","author":"De Pietri","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejim.2016.11.007","article-title":"Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia","volume":"38","author":"Napolitano","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib54","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib55","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1537-2995.2005.00546.x","article-title":"Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review","volume":"45","author":"Segal","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.cgh.2021.07.018_bib56","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4254\/wjh.v7.i4.710","article-title":"Endotipsitis: a case report with a literature review on an emerging prosthetic related infection","volume":"7","author":"Navaratnam","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib57","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1478-3231.2009.02158.x","article-title":"Endotipsitis-persistent infection of transjugular intrahepatic portosystemic shunt: pathogenesis, clinical features and management","volume":"30","author":"Mizrahi","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.07.018_bib58","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jvir.2016.01.137","article-title":"Intravascular ultrasound in the creation of transhepatic portosystemic shunts reduces needle passes, radiation dose, and procedure time: a retrospective study of a single-institution experience","volume":"27","author":"Kao","year":"2016","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib59","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jvir.2016.05.010","article-title":"Utility of intravascular US-guided portal vein access during transjugular intrahepatic portosystemic shunt creation: retrospective comparison with conventional technique in 109 patients","volume":"27","author":"Pillai","year":"2016","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib60","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib61","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib62","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/j.gastro.2017.01.011","article-title":"Timing affects measurement of portal pressure gradient after placement of transjugular intrahepatic portosystemic shunts in patients with portal hypertension","volume":"152","author":"Silva-Junior","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib63","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0016-5085(98)70436-6","article-title":"Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings","volume":"114","author":"Casado","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib64","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/hep.23612","article-title":"Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study","volume":"51","author":"La Mura","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib65","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/S0041-1345(01)02494-0","article-title":"Is transjugular intrahepatic portosystemic shunt really deleterious for liver transplantation issue? A monocentric study on 86 liver transplanted patients","volume":"33","author":"Castellani","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cgh.2021.07.018_bib66","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/BF00299089","article-title":"Impact of transjugular intrahepatic portosystemic shunt on orthotopic liver transplantation","volume":"18","author":"Menegaux","year":"1994","journal-title":"World J Surg"},{"key":"10.1016\/j.cgh.2021.07.018_bib67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.surg.2020.02.017","article-title":"Can pretransplant TIPS be harmful in liver transplantation? A propensity score matching analysis","volume":"168","author":"Matsushima","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.cgh.2021.07.018_bib68","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/lt.500010406","article-title":"Transjugular intrahepatic portosystemic shunts: impact on liver transplantation","volume":"1","author":"Millis","year":"1995","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.cgh.2021.07.018_bib69","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1432-2277.1996.tb00899.x","article-title":"Hemodynamic and metabolic effects of transjugular intrahepatic portosystemic shunt (TIPS) during anesthesia for orthotopic liver transplantation","volume":"9","author":"Antonini","year":"1996","journal-title":"Transpl Int"},{"key":"10.1016\/j.cgh.2021.07.018_bib70","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2214\/AJR.12.8761","article-title":"Covered transjugular intrahepatic portosystemic shunts: accuracy of ultrasound in detecting shunt malfunction","volume":"200","author":"Engstrom","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cgh.2021.07.018_bib71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/2156-7514.186510","article-title":"Transjugular intrahepatic portosystemic shunt dysfunction: concordance of clinical findings, Doppler ultrasound examination, and shunt venography","volume":"6","author":"Owen","year":"2016","journal-title":"J\u00a0Clin Imaging Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib72","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1007\/s00261-019-01981-w","article-title":"Performance of ultrasound for detection of transjugular intrahepatic portosystemic shunt dysfunction: a meta-analysis","volume":"44","author":"Manatsathit","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.cgh.2021.07.018_bib73","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis and management - 2016 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib74","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jvir.2017.08.005","article-title":"Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort","volume":"28","author":"Thornburg","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib75","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","article-title":"Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists","volume":"25","author":"Lebrec","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib76","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A\u00a0comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites","volume":"342","author":"R\u00f6ssle","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib77","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gin\u00e8s","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib78","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","article-title":"The North American Study for the treatment of refractory ascites","volume":"124","author":"Sanyal","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib79","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","article-title":"Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites","volume":"40","author":"Salerno","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib80","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00535-010-0282-9","article-title":"Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial","volume":"46","author":"Narahara","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib81","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1478-3231.2005.01095.x","article-title":"Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis","volume":"25","author":"Deltenre","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.07.018_bib82","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/j.gastro.2005.07.031","article-title":"Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis","volume":"129","author":"D'Amico","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib83","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jhep.2005.06.005","article-title":"A\u00a0meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites","volume":"43","author":"Albillos","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib84","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib85","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3748\/wjg.v20.i10.2704","article-title":"TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis","volume":"20","author":"Bai","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib86","first-page":"CD004889","article-title":"TIPS versus paracentesis for cirrhotic patients with refractory ascites","volume":"4","author":"Saab","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2021.07.018_bib87","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1051-0443(07)61741-2","article-title":"Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax","volume":"13","author":"Spencer","year":"2002","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib88","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diii.2018.10.006","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS) placement: a comparison of outcomes between patients with hepatic hydrothorax and patients with refractory ascites","volume":"100","author":"Young","year":"2019","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.cgh.2021.07.018_bib89","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00042737-200105000-00011","article-title":"Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients","volume":"13","author":"Siegerstetter","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib90","first-page":"6","article-title":"The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients","volume":"70","author":"Wilputte","year":"2007","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.cgh.2021.07.018_bib91","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.510250611","article-title":"The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt","volume":"25","author":"Gordon","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib92","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jvir.2009.10.025","article-title":"Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome","volume":"21","author":"Saad","year":"2010","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib93","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/lt.22281","article-title":"A\u00a0case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation","volume":"17","author":"King","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2021.07.018_bib94","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2214\/AJR.11.7653","article-title":"Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome","volume":"200","author":"Saad","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cgh.2021.07.018_bib95","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/gast.1997.v112.pm9041252","article-title":"The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt","volume":"112","author":"Wong","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib96","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.20386","article-title":"Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding","volume":"40","author":"Monescillo","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib97","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S2468-1253(19)30090-1","article-title":"Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial","volume":"4","author":"Lv","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2012.08.020","article-title":"Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study","volume":"58","author":"Garcia-Pagan","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib99","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/apt.12934","article-title":"Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival","volume":"40","author":"Rudler","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib100","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.dld.2017.08.002","article-title":"Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice","volume":"49","author":"Bucsics","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib101","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.30182","article-title":"Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study","volume":"69","author":"Hern\u00e1ndez-Gea","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib102","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jvir.2016.02.019","article-title":"Transjugular intrahepatic portosystemic shunt creation and variceal coil or plug embolization ineffectively attain gastric variceal decompression or occlusion: results of a 26-patient retrospective study","volume":"27","author":"Lakhoo","year":"2016","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib103","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00330-018-5645-2","article-title":"Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study","volume":"29","author":"Yu","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib104","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/MEG.0000000000001705","article-title":"The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage","volume":"32","author":"Liu","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/MCG.0b013e318203dfb3","article-title":"Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study","volume":"45","author":"Xiao","year":"2011","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib106","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/MEG.0b013e3282eeb488","article-title":"Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis","volume":"19","author":"Biecker","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib107","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/S0002-9270(01)03902-8","article-title":"How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts","volume":"96","author":"R\u00f6ssle","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib108","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jvir.2017.10.014","article-title":"Gastric varices bleed at lower portosystemic pressure gradients than esophageal varices","volume":"29","author":"Morrison","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib109","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jvir.2015.07.001","article-title":"Root cause analysis of rebleeding events following transjugular intrahepatic portosystemic shunt creation for variceal hemorrhage","volume":"26","author":"Lakhoo","year":"2015","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib110","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/jgh.12391","article-title":"Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: a meta-analysis","volume":"29","author":"Qi","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib111","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1148\/radiol.2361040530","article-title":"Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding","volume":"236","author":"Tesdal","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2021.07.018_bib112","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1148\/radiol.13120800","article-title":"Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization","volume":"268","author":"Chen","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2021.07.018_bib113","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jvir.2011.10.015","article-title":"TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period","volume":"23","author":"Gaba","year":"2012","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib114","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s10620-014-3150-2","article-title":"Efficacy of transjugular intrahepatic portosystemic shunt with adjunctive embolotherapy with cyanoacrylate for esophageal variceal bleeding","volume":"59","author":"Shi","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib115","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/003655202320378284","article-title":"Hemodynamic effects of propranolol and nitrates in cirrhotics with transjugular intrahepatic portosystemic stent-shunt","volume":"37","author":"Brensing","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib116","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1155\/2006\/245082","article-title":"Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study","volume":"20","author":"Vinet","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib117","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s11605-018-4053-x","article-title":"Original study: transjugular intrahepatic portosystemic shunt as a bridge to abdominal surgery in cirrhotic patients","volume":"23","author":"Tabchouri","year":"2019","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.cgh.2021.07.018_bib118","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/SLA.0000000000000252","article-title":"When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases","volume":"259","author":"Hibi","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.cgh.2021.07.018_bib119","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/apt.15044","article-title":"Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis","volume":"49","author":"Rodrigues","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib120","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/MEG.0000000000001219","article-title":"The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis","volume":"30","author":"Valentin","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib121","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/MEG.0000000000001067","article-title":"Ten-year experience of transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension","volume":"30","author":"Regnault","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib122","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/apt.15186","article-title":"TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis","volume":"49","author":"Lv","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib123","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.28547","article-title":"Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension","volume":"64","author":"Bissonnette","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib124","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12072-017-9810-5","article-title":"Budd-Chiari syndrome\/hepatic venous outflow tract obstruction","volume":"12","author":"Valla","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2021.07.018_bib125","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3748\/wjg.14.278","article-title":"Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment","volume":"14","author":"Amarapurkar","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib126","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1365-2036.2004.02190.x","article-title":"Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation","volume":"20","author":"Attwell","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib127","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-151-3-200908040-00004","article-title":"Etiology, management, and outcome of the Budd-Chiari syndrome","volume":"151","author":"Darwish Murad","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib128","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/hep.21354","article-title":"Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome","volume":"44","author":"Plessier","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib129","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/apt.13604","article-title":"Hepatic venous outflow tract obstruction: treatment outcomes and development of a new prognostic score","volume":"43","author":"Shalimar","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-230X-10-25","article-title":"Budd-Chiari syndrome: long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt","volume":"10","author":"Zahn","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib131","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.26306","article-title":"Good long-term outcome of Budd-Chiari syndrome with a step-wise management","volume":"57","author":"Seijo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib132","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3748\/wjg.v17.i7.906","article-title":"Outcome of non surgical hepatic decompression procedures in Egyptian patients with Budd-Chiari","volume":"17","author":"Eldorry","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib133","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1148\/radiol.2016152641","article-title":"Long-term outcome and analysis of dysfunction of transjugular intrahepatic portosystemic shunt placement in chronic primary Budd-Chiari syndrome","volume":"283","author":"Hayek","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2021.07.018_bib134","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jvir.2018.01.781","article-title":"Anatomic recanalization of hepatic vein and inferior vena cava versus direct intrahepatic portosystemic shunt creation in Budd-Chiari syndrome: overall outcome and midterm transplant-free survival","volume":"29","author":"Mukund","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib135","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00270-017-1848-1","article-title":"Symptomatic heart failure after transjugular intrahepatic portosystemic shunt placement: incidence, outcomes, and predictors","volume":"41","author":"Modha","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib136","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/hep.30934","article-title":"A\u00a0prospective study identifying predictive factors of cardiac decompensation after transjugular intrahepatic portosystemic shunt: the Toulouse algorithm","volume":"70","author":"Billey","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib137","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/BF02208995","article-title":"Effects of transjugular intrahepatic portasystemic shunt (TIPS) on splanchnic and systemic hemodynamics, and hepatic function in patients with portal hypertension. Preliminary results","volume":"40","author":"Rodr\u00edguez-Laiz","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib138","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","article-title":"Redefining cirrhotic cardiomyopathy for the modern era","volume":"71","author":"Izzy","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cgh.2021.07.018_bib140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/hep4.1308","article-title":"Left ventricular longitudinal contractility predicts acute-on-chronic liver failure development and mortality after transjugular intrahepatic portosystemic shunt","volume":"3","author":"Jansen","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2021.07.018_bib141","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2006.102467","article-title":"Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt","volume":"56","author":"Cazzaniga","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.07.018_bib142","first-page":"385","article-title":"A\u00a0retrospective analysis of the impact of diastolic dysfunction on one-year mortality after transjugular intrahepatic porto-systemic shunt, liver transplantation and non-transplant abdominal surgery in patients with cirrhosis","volume":"28","author":"Shounak","year":"2015","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib143","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International Liver Transplant Society Practice Guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2021.07.018_bib144","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/hep.31415","article-title":"The myths and realities of portopulmonary hypertension","volume":"72","author":"DuBrock","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib145","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1665-2681(19)30848-8","article-title":"Right atrial pressure may impact early survival of patients undergoing transjugular intrahepatic portosystemic shunt creation","volume":"13","author":"Parvinian","year":"2014","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib146","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.dld.2015.08.014","article-title":"Circulatory response to volume expansion and transjugular intrahepatic portosystemic shunt in refractory ascites: relationship with diastolic dysfunction","volume":"47","author":"Fil\u00ec","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib147","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.dld.2017.06.011","article-title":"Effects of transjugular intrahepatic portosystemic shunt (TIPS) on blood volume distribution in patients with cirrhosis","volume":"49","author":"Busk","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib148","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4254\/wjh.v8.i11.520","article-title":"Predictors of mortality after transjugular portosystemic shunt","volume":"8","author":"Ascha","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib149","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jvir.2015.04.017","article-title":"Role of transjugular intrahepatic portosystemic shunts in the management of hepatopulmonary syndrome: a systemic literature review","volume":"26","author":"Tsauo","year":"2015","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib150","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1007\/s00330-018-5840-1","article-title":"Changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome patients with hepatopulmonary syndrome","volume":"29","author":"Tsauo","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib151","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009080","article-title":"Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome","volume":"96","author":"Zhao","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2021.07.018_bib152","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.cgh.2019.03.042","article-title":"Smaller-diameter covered transjugular intrahepatic portosystemic shunt stents are associated with increased survival","volume":"17","author":"Trebicka","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib153","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00270-009-9696-2","article-title":"Short-term effects of transjugular intrahepatic shunt on cardiac function assessed by cardiac MRI: preliminary results","volume":"33","author":"Kovacs","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib154","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jcrc.2014.06.028","article-title":"The effects of transjugular intrahepatic portosystemic stent shunt on systemic cardiocirculatory parameters","volume":"29","author":"Saugel","year":"2014","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.cgh.2021.07.018_bib155","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1665-2681(19)31010-5","article-title":"Transjugular intrahepatic portosystemic shunt is associated with significant changes in mitral inflow parameters","volume":"12","author":"Pudil","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib156","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.510290302","article-title":"Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis","volume":"29","author":"Lotterer","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib157","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1572-0241.2002.05438.x","article-title":"Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS)","volume":"97","author":"Merli","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib158","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jvir.2010.05.009","article-title":"Effect of transjugular intrahepatic portosystemic shunt placement on renal function: a 7-year, single-center experience","volume":"21","author":"Anderson","year":"2010","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib159","first-page":"986","article-title":"Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters","volume":"21","author":"Quiroga","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib160","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.ajkd.2016.02.041","article-title":"Changes in kidney function after transjugular intrahepatic portosystemic shunts versus large-volume paracentesis in cirrhosis: a matched cohort analysis","volume":"68","author":"Allegretti","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib161","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(97)24010-9","article-title":"Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome","volume":"349","author":"Brensing","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2021.07.018_bib162","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.dld.2014.06.013","article-title":"Prognostic factors in patients with refractory ascites treated by transjugular intrahepatic porto-systemic shunt: from the liver to the kidney","volume":"46","author":"Hamel","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib163","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-2036.2007.03443.x","article-title":"Review article: renal function assessment in cirrhosis - difficulties and alternative measurements","volume":"26","author":"Cholongitas","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib164","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A\u00a0model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib165","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00270-018-1923-2","article-title":"Albumin-bilirubin and platelet-albumin-bilirubin grades do not predict survival after transjugular intrahepatic portosystemic shunt creation","volume":"41","author":"Khabbaz","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib166","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/j.1572-0241.2008.02102.x","article-title":"Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts","volume":"103","author":"Riggio","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib167","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gines","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib168","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/jhep.2003.50169","article-title":"Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites","volume":"37","author":"Sola-Vera","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib169","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0016-5085(94)90706-4","article-title":"Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites","volume":"106","author":"Pozzi","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib170","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2215\/CJN.01250119","article-title":"Quality improvement goals for acute kidney injury","volume":"14","author":"Kashani","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cgh.2021.07.018_bib171","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00004836-199504000-00016","article-title":"Hepatorenal syndrome: resolution after transjugular intrahepatic portosystemic shunt","volume":"20","author":"Sturgis","year":"1995","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib172","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.gastro.2003.11.016","article-title":"Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study","volume":"126","author":"Bureau","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib173","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/qjmed\/hcn037","article-title":"Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience","volume":"101","author":"Masson","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.cgh.2021.07.018_bib174","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1111\/j.1440-1746.2010.06400.x","article-title":"Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis","volume":"25","author":"Yang","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib175","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1440-1746.2011.06663.x","article-title":"Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review","volume":"26","author":"Bai","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib176","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10620-014-3391-0","article-title":"Clearing the confusion over hepatic encephalopathy after TIPS creation: incidence, prognostic factors, and clinical outcomes","volume":"60","author":"Casadaban","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib177","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cgh.2016.10.028","article-title":"Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement","volume":"15","author":"Nardelli","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib178","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000025","article-title":"Sarcopenia is associated with development of acute-on-chronic liver failure in decompensated liver cirrhosis receiving transjugular intrahepatic portosystemic shunt","volume":"10","author":"Praktiknjo","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib179","doi-asserted-by":"crossref","first-page":"989","DOI":"10.14309\/ajg.0000000000000603","article-title":"Important unresolved questions in the management of hepatic encephalopathy: an ISHEN consensus","volume":"115","author":"Bajaj","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib180","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by AASLD and EASL","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib181","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26684","article-title":"Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests","volume":"59","author":"Berlioux","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib182","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ajg.2016.29","article-title":"Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt","volume":"111","author":"Nardelli","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib183","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jhep.2008.04.022","article-title":"Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study","volume":"49","author":"Amodio","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib184","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40265-018-1019-y","article-title":"Impact of hepatic encephalopathy in cirrhosis on quality-of-life issues","volume":"79","author":"Montagnese","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.cgh.2021.07.018_bib185","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/ajg.2014.264","article-title":"Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization","volume":"109","author":"Patidar","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib186","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00270-019-02162-4","article-title":"Clinical efficacy of transjugular intrahepatic portosystemic shunt created with expanded polytetrafluoroethylene-covered stent-grafts: 8-mm versus 10-mm","volume":"42","author":"Luo","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib187","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.cgh.2018.01.029","article-title":"Under-dilated TIPS associate with efficacy and reduced encephalopathy in a prospective, non-randomized study of patients with cirrhosis","volume":"16","author":"Schepis","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib188","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2015.05.011","article-title":"Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy","volume":"149","author":"Sauerbruch","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib189","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jhep.2019.12.021","article-title":"Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis","volume":"72","author":"Praktiknjo","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib190","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2018.01.028","article-title":"Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis","volume":"154","author":"Sim\u00f3n-Talero","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib191","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.dld.2018.05.022","article-title":"Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis","volume":"50","author":"He","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib192","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/MEG.0000000000001349","article-title":"Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt","volume":"31","author":"Leng","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib193","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2004.12.028","article-title":"Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study","volume":"42","author":"Riggio","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib194","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/apt.12771","article-title":"Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy","volume":"39","author":"An","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib195","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/hep.26314","article-title":"Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy","volume":"57","author":"Laleman","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib196","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41395-018-0109-5","article-title":"Coil-Assisted Retrograde Transvenous Obliteration (CARTO): an alternative treatment option for refractory hepatic encephalopathy","volume":"113","author":"Lee","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib197","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/lt.24440","article-title":"Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy","volume":"22","author":"Lynn","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2021.07.018_bib198","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/hepr.12181","article-title":"Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: long-term outcomes in 14 patients","volume":"44","author":"Naeshiro","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2021.07.018_bib199","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12664-017-0787-8","article-title":"Shunt occlusion for portosystemic shunt syndrome related refractory hepatic encephalopathy\u2014a single-center experience in 21 patients from Kerala","volume":"36","author":"Philips","year":"2017","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib200","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/M20-0202","article-title":"The use of rifaximin in the prevention of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt : a randomized controlled trial","volume":"174","author":"Bureau","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib201","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cld.2011.12.008","article-title":"Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt","volume":"16","author":"Riggio","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib202","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1440-1746.2006.04697.x","article-title":"Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?","volume":"23","author":"Chung","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib203","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00270-010-0016-7","article-title":"Management of transjugular intrahepatic portosystemic shunt (TIPS)-associated refractory hepatic encephalopathy by shunt reduction using the parallel technique: outcomes of a retrospective case series","volume":"34","author":"Cookson","year":"2011","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib204","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.2214\/AJR.09.2968","article-title":"Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft","volume":"193","author":"Fanelli","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cgh.2021.07.018_bib205","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gut.2005.089482","article-title":"Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy","volume":"55","author":"Kochar","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.07.018_bib206","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jvir.2007.05.009","article-title":"Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study","volume":"18","author":"Maleux","year":"2007","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib207","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2214\/AJR.05.1250","article-title":"Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts","volume":"188","author":"Maleux","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cgh.2021.07.018_bib208","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.1840160607","article-title":"Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients","volume":"16","author":"Sarin","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib224","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.cgh.2021.07.018_bib225","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1287\/mnsc.9.3.458","article-title":"An experimental application of the DELPHI method to the use of experts","volume":"9","author":"Dalkey","year":"1963","journal-title":"Management Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib226","series-title":"The 2011 Oxford CEBM levels of evidence","author":"Howick","year":"2011"},{"key":"10.1016\/j.cgh.2021.07.018_bib227","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.cgh.2021.07.018_bib228","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jvir.2012.10.026","article-title":"Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation","volume":"24","author":"Gaba","year":"2013","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib229","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib230","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib231","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"10.1016\/j.cgh.2021.07.018_bib232","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1572-0241.2003.07515.x","article-title":"Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting","volume":"98","author":"Schepke","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib233","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib234","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10620-010-1390-3","article-title":"Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS","volume":"56","author":"Al Sibae","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib235","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00042737-200406000-00015","article-title":"Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment","volume":"16","author":"Alessandria","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib236","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10620-016-4185-3","article-title":"Transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis and model for end-stage liver disease \u226515","volume":"62","author":"Ascha","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib237","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217442","article-title":"Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement","volume":"14","author":"Allegretti","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2021.07.018_bib238","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1148\/radiol.2311030967","article-title":"Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score","volume":"231","author":"Ferral","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2021.07.018_bib239","article-title":"Short outcome comparison of elderly patients versus nonelderly patients treated with transjugular intrahepatic portosystemic stent shunt: a propensity score matched cohort study","volume":"96","author":"Li","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2021.07.018_bib240","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/MCG.0000000000000541","article-title":"Age-related morbidity and mortality after transjugular intrahepatic portosystemic shunts","volume":"51","author":"Suraweera","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib241","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jhep.2020.04.024","article-title":"Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS","volume":"73","author":"Trebicka","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib242","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","article-title":"Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites","volume":"152","author":"Bureau","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib243","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2017.05.006","article-title":"Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding","volume":"67","author":"Wang","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib244","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1148\/radiol.2017161644","article-title":"Transjugular intrahepatic portosystemic shunts in patients with cirrhosis with refractory ascites: comparison of clinical outcomes by using 8- and 10-mm PTFE-covered stents","volume":"284","author":"Miraglia","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2021.07.018_bib245","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ki.1995.32","article-title":"Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study","volume":"47","author":"Rudnick","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.cgh.2021.07.018_bib246","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0002-9343(89)90437-3","article-title":"Dosing of contrast material to prevent contrast nephropathy in patients with renal disease","volume":"86","author":"Cigarroa","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib247","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.21037\/cdt.2017.10.03","article-title":"Risk factors for stent graft thrombosis after transjugular intrahepatic portosystemic shunt creation","volume":"7","author":"Jahangiri","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib248","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib249","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","article-title":"Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists","volume":"25","author":"Lebrec","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib250","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A\u00a0comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites","volume":"342","author":"R\u00f6ssle","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib251","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gin\u00e8s","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib252","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","article-title":"The North American Study for the Treatment of Refractory Ascites","volume":"124","author":"Sanyal","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib253","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","article-title":"Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites","volume":"40","author":"Salerno","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib254","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00535-010-0282-9","article-title":"Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial","volume":"46","author":"Narahara","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib255","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1478-3231.2005.01095.x","article-title":"Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis","volume":"25","author":"Deltenre","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.07.018_bib256","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/j.gastro.2005.07.031","article-title":"Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis","volume":"129","author":"D'Amico","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib257","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jhep.2005.06.005","article-title":"A\u00a0meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites","volume":"43","author":"Albillos","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib258","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib259","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3748\/wjg.v20.i10.2704","article-title":"TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis","volume":"20","author":"Bai","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib260","article-title":"TIPS versus paracentesis for cirrhotic patients with refractory ascites","volume":"4","author":"Saab","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2021.07.018_bib261","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0041-1345(03)00514-1","article-title":"Management of massive and persistent ascites and\/or hydrothorax after liver transplantation","volume":"35","author":"Urbani","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cgh.2021.07.018_bib262","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/lt.22280","article-title":"Splenic artery embolization for the treatment of refractory ascites after liver transplantation","volume":"17","author":"Quintini","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2021.07.018_bib263","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.transproceed.2008.03.083","article-title":"Mesocaval shunt as an alternative treatment for persistent ascites after liver transplantation: case reports","volume":"40","author":"Taner","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cgh.2021.07.018_bib264","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis and management - 2016 practice guidance by the American Association for the Study of Liver Diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib265","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/ajg.2012.313","article-title":"The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors","volume":"107","author":"Amitrano","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib266","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2007.10.008","article-title":"Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy","volume":"48","author":"Abraldes","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib267","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s10620-018-5412-x","article-title":"Predictors of re-bleeding and mortality among patients with refractory variceal bleeding undergoing salvage transjugular intrahepatic portosystemic shunt (TIPS)","volume":"64","author":"Maimone","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib268","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.20386","article-title":"Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding","volume":"40","author":"Monescillo","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib269","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garcia-Pagan","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib270","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S2468-1253(19)30090-1","article-title":"Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial","volume":"4","author":"Lv","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib271","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2012.08.020","article-title":"Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study","volume":"58","author":"Garcia-Pagan","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib272","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/apt.12934","article-title":"Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival","volume":"40","author":"Rudler","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib273","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.dld.2017.08.002","article-title":"Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice","volume":"49","author":"Bucsics","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib274","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.30182","article-title":"Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study","volume":"69","author":"Hern\u00e1ndez-Gea","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib275","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/gutjnl-2018-317057","article-title":"Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study","volume":"68","author":"Lv","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.07.018_bib276","doi-asserted-by":"crossref","first-page":"910986","DOI":"10.1155\/2011\/910986","article-title":"Self-expandable metal stents in the treatment of acute esophageal variceal bleeding","volume":"2011","author":"Escorsell","year":"2011","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.cgh.2021.07.018_bib277","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1055\/s-2007-966591","article-title":"A\u00a0prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding","volume":"39","author":"Lo","year":"2007","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2021.07.018_bib278","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/j.1572-0241.2003.08769.x","article-title":"Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding","volume":"98","author":"Mahadeva","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib279","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jvir.2017.10.014","article-title":"Gastric varices bleed at lower portosystemic pressure gradients than esophageal varices","volume":"29","author":"Morrison","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib280","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5009\/gnl17515","article-title":"Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for the management of gastric variceal bleeding","volume":"12","author":"Gimm","year":"2018","journal-title":"Gut Liver"},{"key":"10.1016\/j.cgh.2021.07.018_bib281","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3348\/kjr.2003.4.2.109","article-title":"Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt","volume":"4","author":"Choi","year":"2003","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib282","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3348\/kjr.2017.18.2.345","article-title":"Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde transvenous obliteration in managing isolated gastric varices","volume":"18","author":"Kim","year":"2017","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib283","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/jgh.13729","article-title":"Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis","volume":"32","author":"Lee","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib284","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jvir.2013.12.001","article-title":"Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration","volume":"25","author":"Sabri","year":"2014","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib285","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/jgh.13248","article-title":"Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension: a meta-analysis","volume":"31","author":"Wang","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib286","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/MCG.0000000000001275","article-title":"Balloon-occluded retrograde transvenous obliteration (BRTO) versus transjugular intrahepatic portosystemic shunt (TIPS) for treatment of gastric varices because of portal hypertension: a systematic review and meta-analysis","volume":"54","author":"Paleti","year":"2020","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib287","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MCG.0000000000001305","article-title":"Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for gastric varices: a meta-analysis","volume":"55","author":"Yu","year":"2021","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib288","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jvir.2016.02.019","article-title":"Transjugular intrahepatic portosystemic shunt creation and variceal coil or plug embolization ineffectively attain gastric variceal decompression or occlusion: results of a 26-patient retrospective study","volume":"27","author":"Lakhoo","year":"2016","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib289","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00330-018-5645-2","article-title":"Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study","volume":"29","author":"Yu","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib290","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/MEG.0000000000001705","article-title":"The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage","volume":"32","author":"Liu","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib291","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2214\/AJR.11.7653","article-title":"Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome","volume":"200","author":"Saad","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cgh.2021.07.018_bib292","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0016-5085(98)70436-6","article-title":"Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings","volume":"114","author":"Casado","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib293","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00270-018-2040-y","article-title":"transjugular intrahepatic portosystemic shunt using the new Gore Viatorr controlled expansion endoprosthesis: prospective, single-center, preliminary experience","volume":"42","author":"Miraglia","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib294","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/MCG.0b013e318203dfb3","article-title":"Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study","volume":"45","author":"Xiao","year":"2011","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib295","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/MEG.0b013e3282eeb488","article-title":"Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis","volume":"19","author":"Biecker","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib296","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/S0002-9270(01)03902-8","article-title":"How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts","volume":"96","author":"R\u00f6ssle","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib297","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2010.02.033","article-title":"Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial","volume":"53","author":"Riggio","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib298","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jvir.2015.07.001","article-title":"Root cause analysis of rebleeding events following transjugular intrahepatic portosystemic shunt creation for variceal hemorrhage","volume":"26","author":"Lakhoo","year":"2015","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib299","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/jgh.12391","article-title":"Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: a meta-analysis","volume":"29","author":"Qi","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib300","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1148\/radiol.2361040530","article-title":"Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding","volume":"236","author":"Tesdal","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2021.07.018_bib301","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1148\/radiol.13120800","article-title":"Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization","volume":"268","author":"Chen","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2021.07.018_bib302","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jvir.2011.10.015","article-title":"TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period","volume":"23","author":"Gaba","year":"2012","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib303","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s10620-014-3150-2","article-title":"Efficacy of transjugular intrahepatic portosystemic shunt with adjunctive embolotherapy with cyanoacrylate for esophageal variceal bleeding","volume":"59","author":"Shi","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib304","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s00270-007-9089-3","article-title":"Embolization with the Amplatzer Vascular Plug in TIPS patients","volume":"30","author":"Pattynama","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib305","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2214\/AJR.16.16012","article-title":"Comparison of vascular plugs and pushable coils for variceal embolization after TIPS","volume":"208","author":"Sarwar","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cgh.2021.07.018_bib306","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00270-019-02176-y","article-title":"Adjuvant transjugular variceal occlusion at creation of a transjugular intrahepatic portosystemic shunt (TIPS): efficacy and risks of bucrylate embolization","volume":"42","author":"Schulthei\u00df","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib307","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/0284185115595060","article-title":"Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver","volume":"57","author":"Rosenqvist","year":"2016","journal-title":"Acta Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib308","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.dld.2017.05.020","article-title":"Transjugular local thrombolysis with\/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis","volume":"49","author":"Klinger","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib309","first-page":"221","article-title":"Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis","volume":"56","author":"Klinger","year":"2018","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.diii.2018.07.009","article-title":"Percutaneous portal vein recanalization using self-expandable nitinol stents in patients with non-cirrhotic non-tumoral portal vein occlusion","volume":"100","author":"Marot","year":"2019","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.cgh.2021.07.018_bib311","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/bloodadvances.2019001310","article-title":"The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis","volume":"4","author":"Naymagon","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.cgh.2021.07.018_bib312","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3748\/wjg.14.278","article-title":"Changing spectrum of Budd-Chiari syndrome in India with special reference to non-surgical treatment","volume":"14","author":"Amarapurkar","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib313","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1365-2036.2004.02190.x","article-title":"Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation","volume":"20","author":"Attwell","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib314","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/0003-4819-151-3-200908040-00004","article-title":"Etiology, management, and outcome of the Budd-Chiari syndrome","volume":"151","author":"Darwish Murad","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib315","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/hep.21354","article-title":"Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome","volume":"44","author":"Plessier","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib316","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/apt.13604","article-title":"Hepatic venous outflow tract obstruction: treatment outcomes and development of a new prognostic score","volume":"43","author":"Shalimar","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib317","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-230X-10-25","article-title":"Budd-Chiari syndrome: long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt","volume":"10","author":"Zahn","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib318","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.26306","article-title":"Good long-term outcome of Budd-Chiari syndrome with a step-wise management","volume":"57","author":"Seijo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib319","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3748\/wjg.v17.i7.906","article-title":"Outcome of non surgical hepatic decompression procedures in Egyptian patients with Budd-Chiari","volume":"17","author":"Eldorry","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib320","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012944","article-title":"Excellent long-term outcomes of endovascular treatment in Budd-Chiari syndrome with hepatic veins involvement: a STROBE-compliant article","volume":"97","author":"Bi","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2021.07.018_bib321","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00270-019-02267-w","article-title":"Interventional treatment strategy for primary Budd-Chiari syndrome with both inferior vena cava and hepatic vein involvement: patients from two centers in China","volume":"42","author":"Cheng","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib322","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1007\/s10620-016-4208-0","article-title":"Good clinical outcomes in Budd-Chiari syndrome with hepatic vein occlusion","volume":"61","author":"Fan","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib323","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1148\/radiol.12120856","article-title":"Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center","volume":"266","author":"Han","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2021.07.018_bib324","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jgh.13456","article-title":"Endovascular treatment of Budd-Chiari syndrome: single center experience","volume":"32","author":"Rathod","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib325","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/liv.13180","article-title":"Long-term outcomes following percutaneous hepatic vein recanalization for Budd-Chiari syndrome","volume":"37","author":"Tripathi","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.07.018_bib326","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/gut.2005.071423","article-title":"Favourable medium term outcome following hepatic vein recanalisation and\/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome","volume":"55","author":"Eapen","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.07.018_bib327","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/imj.13544","article-title":"Early radiological intervention and haematology screening is associated with excellent outcomes in Budd-Chiari syndrome","volume":"47","author":"Mo","year":"2017","journal-title":"Intern Med J"},{"key":"10.1016\/j.cgh.2021.07.018_bib328","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/liv.12355","article-title":"Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre","volume":"34","author":"Qi","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.07.018_bib329","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2214\/AJR.07.3496","article-title":"Percutaneous sonographic guidance for TIPS in Budd-Chiari syndrome: direct simultaneous puncture of the portal vein and inferior vena cava","volume":"191","author":"Boyvat","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cgh.2021.07.018_bib330","first-page":"86","article-title":"Ultrasound-guided direct intrahepatic portosystemic shunt in patients with Budd-Chiari syndrome: short- and long-term results","volume":"9","author":"Hatzidakis","year":"2017","journal-title":"Interv Med Appl Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib331","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/lt.24643","article-title":"Budd-Chiari syndrome causing acute liver failure: a multicenter case series","volume":"23","author":"Parekh","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2021.07.018_bib332","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1053\/j.gastro.2008.05.051","article-title":"TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients","volume":"135","author":"Garcia-Pag\u00e1n","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib333","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1148\/radiol.2016152641","article-title":"Long-term outcome and analysis of dysfunction of transjugular intrahepatic portosystemic shunt placement in chronic primary Budd-Chiari syndrome","volume":"283","author":"Hayek","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2021.07.018_bib334","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jvir.2018.01.781","article-title":"Anatomic recanalization of hepatic vein and inferior vena cava versus direct intrahepatic portosystemic shunt creation in Budd-Chiari syndrome: overall outcome and midterm transplant-free survival","volume":"29","author":"Mukund","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib335","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00270-013-0697-9","article-title":"Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: results from a single center","volume":"37","author":"Fitsiori","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib336","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/apt.12668","article-title":"Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome","volume":"39","author":"Tripathi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib337","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","article-title":"Redefining cirrhotic cardiomyopathy for the modern era","volume":"71","author":"Izzy","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib338","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cgh.2021.07.018_bib339","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jvir.2015.04.017","article-title":"Role of transjugular intrahepatic portosystemic shunts in the management of hepatopulmonary syndrome: a systemic literature review","volume":"26","author":"Tsauo","year":"2015","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib340","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1007\/s00330-018-5840-1","article-title":"Changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome patients with hepatopulmonary syndrome","volume":"29","author":"Tsauo","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib341","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009080","article-title":"Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome","volume":"96","author":"Zhao","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2021.07.018_bib342","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.transproceed.2004.03.117","article-title":"Complications following transjugular intrahepatic portosystemic shunt: a retrospective analysis","volume":"36","author":"Silva","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cgh.2021.07.018_bib343","first-page":"725","article-title":"The risk of acute kidney injury with transjugular intrahepatic portosystemic shunts","volume":"28","author":"Danziger","year":"2015","journal-title":"J\u00a0Nephrol"},{"issue":"2","key":"10.1016\/j.cgh.2021.07.018_bib344","first-page":"8","article-title":"Summary of recommendation statements","volume":"2012","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.cgh.2021.07.018_bib345","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.3748\/wjg.v22.i25.5780","article-title":"Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt","volume":"22","author":"Lee","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib346","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jvir.2010.05.009","article-title":"Effect of transjugular intrahepatic portosystemic shunt placement on renal function: a 7-year, single-center experience","volume":"21","author":"Anderson","year":"2010","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib347","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib348","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(97)24010-9","article-title":"Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome","volume":"349","author":"Brensing","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2021.07.018_bib349","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.ajkd.2016.02.041","article-title":"Changes in kidney function after transjugular intrahepatic portosystemic shunts versus large-volume paracentesis in cirrhosis: a matched cohort analysis","volume":"68","author":"Allegretti","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib350","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1018861827399","article-title":"Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution","volume":"42","author":"Martinet","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib351","first-page":"1753","article-title":"Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation","volume":"50","author":"Testino","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib352","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ki.1979.8","article-title":"Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome","volume":"15","author":"Schroeder","year":"1979","journal-title":"Kidney Int"},{"key":"10.1016\/j.cgh.2021.07.018_bib353","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.07.018_bib354","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jvir.2007.11.011","article-title":"Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy","volume":"19","author":"Haskal","year":"2008","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib355","first-page":"986","article-title":"Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters","volume":"21","author":"Quiroga","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib356","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.dld.2014.06.013","article-title":"Prognostic factors in patients with refractory ascites treated by transjugular intrahepatic porto-systemic shunt: from the liver to the kidney","volume":"46","author":"Hamel","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib357","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/jlts.2002.31653","article-title":"Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt","volume":"8","author":"Russo","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2021.07.018_bib358","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/j.1572-0241.2003.08664.x","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality","volume":"98","author":"Russo","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib359","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1053\/gast.1997.v112.pm9041252","article-title":"The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt","volume":"112","author":"Wong","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib360","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1572-0241.1999.01112.x","article-title":"Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites","volume":"94","author":"Desch\u00eanes","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib361","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-2036.2007.03443.x","article-title":"Review article: renal function assessment in cirrhosis - difficulties and alternative measurements","volume":"26","author":"Cholongitas","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib362","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/hep.26556","article-title":"Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis","volume":"59","author":"Mindikoglu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib363","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2016.05.025","article-title":"Kidney biomarkers in cirrhosis","volume":"65","author":"Francoz","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib364","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2020.03.016","article-title":"Clinical application of kidney biomarkers in cirrhosis","volume":"76","author":"Allegretti","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib365","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/hep.27031","article-title":"Reconsidering a \"chopped liver\": the need for improving glomular filtration rate estimation for hepatic transplantation","volume":"59","author":"Parikh","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib366","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/liv.14230","article-title":"Sex specificity of kidney markers to assess prognosis in cirrhotic patients with TIPS","volume":"40","author":"Torner","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.07.018_bib367","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gines","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib368","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/jhep.2003.50169","article-title":"Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites","volume":"37","author":"Sola-Vera","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib369","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0016-5085(94)90706-4","article-title":"Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites","volume":"106","author":"Pozzi","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib370","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1478-3231.2008.01734.x","article-title":"Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study","volume":"28","author":"Appenrodt","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.07.018_bib371","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MCG.0b013e31829ae376","article-title":"Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study","volume":"48","author":"Hamdy","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib372","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2796.2006.01654.x","article-title":"Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study","volume":"260","author":"Singh","year":"2006","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib373","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1746.2006.04182.x","article-title":"Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study","volume":"21","author":"Singh","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib374","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1148\/radiol.2017161573","article-title":"Is intravenous administration of iodixanol associated with increased risk of acute kidney injury, dialysis, or mortality? A propensity score-adjusted study","volume":"285","author":"McDonald","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2021.07.018_bib375","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1681\/ASN.2016010021","article-title":"Estimating the risk of radiocontrast-associated nephropathy","volume":"28","author":"Wilhelm-Leen","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cgh.2021.07.018_bib376","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.ajkd.2019.05.022","article-title":"The controversy of contrast-induced nephropathy with intravenous contrast: what is the risk?","volume":"75","author":"Rudnick","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib377","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1148\/radiol.13122276","article-title":"Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate","volume":"268","author":"Davenport","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2021.07.018_bib378","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1710933","article-title":"Outcomes after angiography with sodium bicarbonate and acetylcysteine","volume":"378","author":"Weisbord","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib379","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jacc.2009.09.072","article-title":"Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography","volume":"55","author":"Stolker","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib380","article-title":"Severe hyperbilirubinemia is associated with higher risk of contrast-related acute kidney injury following contrast-enhanced computed tomography","volume":"15","author":"Wu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2021.07.018_bib381","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib382","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.dld.2018.01.123","article-title":"Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: a systematic review and meta-analysis","volume":"50","author":"Song","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib383","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.gastro.2003.11.016","article-title":"Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study","volume":"126","author":"Bureau","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib384","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/qjmed\/hcn037","article-title":"Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience","volume":"101","author":"Masson","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.cgh.2021.07.018_bib385","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1111\/j.1440-1746.2010.06400.x","article-title":"Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis","volume":"25","author":"Yang","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib386","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1440-1746.2011.06663.x","article-title":"Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review","volume":"26","author":"Bai","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib387","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10620-014-3391-0","article-title":"Clearing the confusion over hepatic encephalopathy after TIPS creation: incidence, prognostic factors, and clinical outcomes","volume":"60","author":"Casadaban","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib388","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/j.1572-0241.2008.02102.x","article-title":"Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts","volume":"103","author":"Riggio","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib389","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cgh.2016.10.028","article-title":"Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement","volume":"15","author":"Nardelli","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib390","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000025","article-title":"sarcopenia is associated with development of acute-on-chronic liver failure in decompensated liver cirrhosis receiving transjugular intrahepatic portosystemic shunt","volume":"10","author":"Praktiknjo","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib391","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26684","article-title":"Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests","volume":"59","author":"Berlioux","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib392","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ajg.2016.29","article-title":"Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt","volume":"111","author":"Nardelli","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib393","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jhep.2008.04.022","article-title":"Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study","volume":"49","author":"Amodio","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib394","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40265-018-1019-y","article-title":"Impact of hepatic encephalopathy in cirrhosis on quality-of-life issues","volume":"79","author":"Montagnese","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.cgh.2021.07.018_bib395","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/ajg.2014.264","article-title":"Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization","volume":"109","author":"Patidar","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib396","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by AASLD and EASL","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib397","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/liv.14297","article-title":"Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathy","volume":"40","author":"Ampuero","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.07.018_bib398","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0168-8278(02)00330-6","article-title":"Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy","volume":"37","author":"Romero-G\u00f3mez","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib399","first-page":"277","article-title":"Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis","volume":"22","author":"Trifan","year":"2013","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib400","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.cgh.2014.05.011","article-title":"Validation of EncephalApp, Smartphone-Based Stroop Test, for the diagnosis of covert hepatic encephalopathy","volume":"13","author":"Bajaj","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib401","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2015.05.011","article-title":"Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy","volume":"149","author":"Sauerbruch","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib402","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00270-019-02162-4","article-title":"Clinical efficacy of transjugular intrahepatic portosystemic shunt created with expanded polytetrafluoroethylene-covered stent-grafts: 8-mm versus 10-mm","volume":"42","author":"Luo","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib403","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.cgh.2018.01.029","article-title":"Under-dilated TIPS associate with efficacy and reduced encephalopathy in a prospective, non-randomized study of patients with cirrhosis","volume":"16","author":"Schepis","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib404","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jhep.2019.12.021","article-title":"Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis","volume":"72","author":"Praktiknjo","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib405","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2018.01.028","article-title":"Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis","volume":"154","author":"Sim\u00f3n-Talero","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib406","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.dld.2018.05.022","article-title":"Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis","volume":"50","author":"He","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib407","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/MEG.0000000000001349","article-title":"Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt","volume":"31","author":"Leng","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib408","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2004.12.028","article-title":"Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study","volume":"42","author":"Riggio","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib409","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/M20-0202","article-title":"The use of rifaximin in the prevention of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt : a randomized controlled trial","volume":"174","author":"Bureau","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib410","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1155\/2006\/245082","article-title":"Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study","volume":"20","author":"Vinet","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib411","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s11605-018-4053-x","article-title":"Original study: transjugular intrahepatic portosystemic shunt as a bridge to abdominal surgery in cirrhotic patients","volume":"23","author":"Tabchouri","year":"2019","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.cgh.2021.07.018_bib412","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.dld.2010.06.001","article-title":"Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma","volume":"43","author":"Fanelli","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib413","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s10620-011-1975-5","article-title":"Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients","volume":"57","author":"Qi","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.018_bib414","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.28547","article-title":"Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension","volume":"64","author":"Bissonnette","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib415","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/MEG.0000000000001067","article-title":"Ten-year experience of transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension","volume":"30","author":"Regnault","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib416","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/apt.15186","article-title":"TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis","volume":"49","author":"Lv","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.018_bib417","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3748\/wjg.v23.i4.629","article-title":"Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: a single-center study","volume":"23","author":"Sakr","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib418","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib419","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2215\/CJN.01340406","article-title":"Hepatorenal syndrome: pathophysiology and management","volume":"1","author":"Wadei","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cgh.2021.07.018_bib420","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gines","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib421","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.2009.193227","article-title":"TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update","volume":"59","author":"Rossle","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.07.018_bib422","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1665-2681(19)31677-1","article-title":"Effects of TIPS on global end-diastolic volume and cardiac output and renal resistive index in ICU patients with advanced alcoholic cirrhosis","volume":"9","author":"Umgelter","year":"2010","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib423","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.018_bib424","first-page":"709","article-title":"Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function","volume":"21","author":"Somberg","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib425","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/hep.510280313","article-title":"Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites","volume":"28","author":"Gerbes","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.07.018_bib426","doi-asserted-by":"crossref","first-page":"G275","DOI":"10.1152\/ajpgi.00094.2017","article-title":"Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis","volume":"314","author":"Busk","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cgh.2021.07.018_bib427","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.dld.2017.06.011","article-title":"Effects of transjugular intrahepatic portosystemic shunt (TIPS) on blood volume distribution in patients with cirrhosis","volume":"49","author":"Busk","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.07.018_bib428","doi-asserted-by":"crossref","first-page":"816","DOI":"10.7326\/0003-4819-122-11-199506010-00002","article-title":"Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites","volume":"122","author":"Wong","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib429","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00042737-199611000-00015","article-title":"Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS)","volume":"8","author":"Jalan","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.018_bib430","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/gut.40.5.664","article-title":"Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man?","volume":"40","author":"Jalan","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.07.018_bib431","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/003655200750023642","article-title":"Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic or functional renal failure","volume":"35","author":"Michl","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.018_bib432","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0002-9343(99)00029-7","article-title":"Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites","volume":"106","author":"Wong","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2021.07.018_bib433","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1111\/j.1572-0241.1998.00705.x","article-title":"Acute effects of transjugular intrahepatic portosystemic stent-shunt (TIPSS) procedure on renal blood flow and cardiopulmonary hemodynamics in cirrhosis","volume":"93","author":"Stanley","year":"1998","journal-title":"Am J Gastroenterol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521007497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521007497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:38:27Z","timestamp":1761543507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356521007497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":417,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1542356521007497"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2021.07.018","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2021.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the AGA Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}